DM

Daniel Mutnick

IR Irm: 7 patents #35 of 277Top 15%
NA Novartis Ag: 4 patents #1,111 of 5,128Top 25%
Overall (All Time): #452,916 of 4,157,543Top 15%
11
Patents All Time

Issued Patents All Time

Patent #TitleCo-InventorsDate
10954233 Compounds and compositions as inhibitors of endosomal toll-like receptors Phillip Alper, Jonathan Deane, Songchun Jiang, Tao Jiang, Thomas Knoepfel +5 more 2021-03-23
10160726 Quinolone derivatives as antibacterials Javier de Vicente Fidalgo, Haiying He, Cheng Hu, Zhigan Jiang, Xiaolin Li +8 more 2018-12-25
9150568 Compositions and methods for modulating FXR David C. Tully, Paul V. Rucker, Phillip Alper, Donatella Chianelli 2015-10-06
8268996 Compounds and compositions as cathepsin S inhibitors Hong Liu, David C. Tully, Arnab K. Chatterjee, Phillip Alper, David H. Woodmansee 2012-09-18
8153671 Heterotetracyclic compounds as TPO mimetics Phillip Alper, Thomas H. Marsilje, Arnab K. Chatterjee, Wenshuo Lu, Michael Stephen Roberts +1 more 2012-04-10
8153635 Compounds and compositions as modulators of GPR119 activity Phillip Alper, Mihai Azimioara, Christopher Cow, Robert Epple, Songchun Jiang +3 more 2012-04-10
7985749 Compounds and compositions as cathepsin S inhibitors Hong Liu, David C. Tully, Arnab K. Chatterjee, Phillip Alper, David H. Woodmansee 2011-07-26
7816542 Compounds and compositions as TPO mimetics Thomas H. Marsilje, Wenshuo Lu, Phillip Alper, Yun He 2010-10-19
7501408 Inhibitors of cathepsin S Hong Liu, Arnab K. Chatterjee, David C. Tully, Phillip Alper, Badry Bursulaya +4 more 2009-03-10
7314872 Inhibitors of cathepsin S Hong Liu, Arnab K. Chatterjee, David C. Tully, Phillip Alper, Badry Bursulaya +4 more 2008-01-01
7297714 Inhibitors of cathepsin S Hong Liu, Phillip Alper, Donald S. Karanewsky 2007-11-20